Clinical Edge Journal Scan

Robotic nipple-sparing mastectomy may soon become a feasible option in BC


 

Key clinical point: Robotic nipple-sparing mastectomy (RNSM) may soon become a viable option for breast cancer (BC) surgery as it is associated with lower postoperative complication rates than conventional NSM (CNSM).

Major finding: RNSM vs CNSM was associated with a significantly lower rate of nipple necrosis, a major postoperative complication (odds ratio 0.54; P = .03), and intraoperative blood loss (mean difference [MD] −53.18 mL; P < .00001), but a significantly higher operating time (MD +58.81 min; P < .001).

Study details: Findings are from a meta-analysis of seven studies including 1674 women with BC who underwent RNSM (50.9%) or CNSM (49.1%).

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Nessa A et al. Postoperative complications and surgical outcomes of robotic versus conventional nipple-sparing mastectomy in breast cancer: Meta-analysis. Br J Surg. 2023 (Oct 27). doi: 10.1093/bjs/znad336

Recommended Reading

Particulate pollution increases the risk for breast cancer
MDedge Hematology and Oncology
An 88-year-old Black woman presented with 3 months duration of asymptomatic, violaceous patches on the left breast
MDedge Hematology and Oncology
Highlights in Early Breast Cancer From ESMO 2023
MDedge Hematology and Oncology
Obesity is a risk factor for recurrence in aromatase inhibitor-treated HR+ BC
MDedge Hematology and Oncology
Meta-analysis shows benefits of regional node irradiation in early BC
MDedge Hematology and Oncology
Dual HER2 inhibition with pyrotinib-trastuzumab-docetaxel confers survival benefits in untreated HER2+ metastatic BC
MDedge Hematology and Oncology
Is gel tamoxifen noninferior to oral tamoxifen in DCIS of the breast?
MDedge Hematology and Oncology
Screening programs can improve disease-free interval outcomes in BC
MDedge Hematology and Oncology
Pregnancy is safe for women with a prior diagnosis of HR+ early BC
MDedge Hematology and Oncology
Adjuvant chemotherapy beneficial in small-size node-negative TNBC
MDedge Hematology and Oncology